Reaction Details |
| Report a problem with these data |
Target | Histone acetyltransferase KAT2B |
---|
Ligand | BDBM371554 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | PCAF AlphaLisa Binding Assay |
---|
IC50 | 155±n/a nM |
---|
Citation | Albrecht, BK; Burdick, DJ; Cote, A; Duplessis, M; Nasveschuk, CG; Taylor, AM Therapeutic compounds and uses thereof US Patent US10239861 Publication Date 3/26/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Histone acetyltransferase KAT2B |
---|
Name: | Histone acetyltransferase KAT2B |
Synonyms: | Histone acetyltransferase KAT2A/KAT2B | Histone acetyltransferase PCAF | KAT2B | KAT2B_HUMAN | PCAF |
Type: | PROTEIN |
Mol. Mass.: | 93045.76 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_1502838 |
Residue: | 832 |
Sequence: | MSEAGGAGPGGCGAGAGAGAGPGALPPQPAALPPAPPQGSPCAAAAGGSGACGPATAVAA
AGTAEGPGGGGSARIAVKKAQLRSAPRAKKLEKLGVYSACKAEESCKCNGWKNPNPSPTP
PRADLQQIIVSLTESCRSCSHALAAHVSHLENVSEEEMNRLLGIVLDVEYLFTCVHKEED
ADTKQVYFYLFKLLRKSILQRGKPVVEGSLEKKPPFEKPSIEQGVNNFVQYKFSHLPAKE
RQTIVELAKMFLNRINYWHLEAPSQRRLRSPNDDISGYKENYTRWLCYCNVPQFCDSLPR
YETTQVFGRTLLRSVFTVMRRQLLEQARQEKDKLPLEKRTLILTHFPKFLSMLEEEVYSQ
NSPIWDQDFLSASSRTSQLGIQTVINPPPVAGTISYNSTSSSLEQPNAGSSSPACKASSG
LEANPGEKRKMTDSHVLEEAKKPRVMGDIPMELINEVMSTITDPAAMLGPETNFLSAHSA
RDEAARLEERRGVIEFHVVGNSLNQKPNKKILMWLVGLQNVFSHQLPRMPKEYITRLVFD
PKHKTLALIKDGRVIGGICFRMFPSQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKH
DILNFLTYADEYAIGYFKKQGFSKEIKIPKTKYVGYIKDYEGATLMGCELNPRIPYTEFS
VIIKKQKEIIKKLIERKQAQIRKVYPGLSCFKDGVRQIPIESIPGIRETGWKPSGKEKSK
EPRDPDQLYSTLKSILQQVKSHQSAWPFMEPVKRTEAPGYYEVIRFPMDLKTMSERLKNR
YYVSKKLFMADLQRVFTNCKEYNPPESEYYKCANILEKFFFSKIKEAGLIDK
|
|
|
BDBM371554 |
---|
n/a |
---|
Name | BDBM371554 |
Synonyms: | US10239861, Example 34 | racemic-5-((1-benzylpiperidin-3-yl)amino)-4-chloro-2-methylpyridazin-3(2H)-one |
Type | Small organic molecule |
Emp. Form. | C17H21ClN4O |
Mol. Mass. | 332.828 |
SMILES | Cn1ncc(NC2CCCN(Cc3ccccc3)C2)c(Cl)c1=O |
Structure |
|